In Parkinson's disease, alterations in mitochondrial transport occur in response to rotenone treatment and pink1 has been shown to interact with Milton and Miro, two key proteins responsible for the interaction of mitochondria with neuronal motor proteins (Arnold et al., 2011; Weihofen et al., 2009). Here, PINK1 is linked to Parkinson disease.